Regents of the University of California’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Regents of the University of California’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-16,110	Closed	-$44K	–	26
2018 Q1	$44K	Hold	16,110	–	–	0.08%	22
2017 Q4	$50K	Hold	16,110	–	–	0.08%	26
2017 Q3	$45K	Buy	+16,110	New	+$43.5K	0.09%	20
2016 Q4	–	Sell	-16,110	Closed	-$743K	–	28
2016 Q3	$743K	Hold	16,110	–	–	2.12%	19
2016 Q2	$822K	Hold	16,110	–	–	2.77%	14
2016 Q1	$681K	Hold	16,110	–	–	2.36%	13
2015 Q4	$1.26M	Hold	16,110	–	–	3.92%	7
2015 Q3	$653K	Hold	16,110	–	–	2.05%	14
2015 Q2	$839K	Hold	16,110	–	–	2.36%	11
2015 Q1	$750K	Sell	16,110 -16,110	-50%	-$836K	0.76%	65
2014 Q4	$1.45M	Hold	32,220	–	–	1.44%	20
2014 Q3	$1.25M	Hold	32,220	–	–	0.71%	61
2014 Q2	$1.36M	Buy	+32,220	New	+$1.18M	0.74%	61

Other funds holding ISEE

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Regents of the University of California's ISEE Position: Q2 2018 in Review

Regents of the University of California sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2018, closing a stake of 16,110 shares — an estimated $44K sold.

Regents of the University of California first reported a position in ISEE in Q2 2014 and held it in 13 quarters. The position peaked at $1.45M in Q4 2014. 73 funds tracked by Wall St. Rank hold ISEE as of Q2 2018.

Regents of the University of California reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Regents of the University of California sold 16,110 IVERIC bio, Inc. Common Stock shares in Q2 2018, an estimated $44K.
Regents of the University of California first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 13 quarters.
Regents of the University of California's IVERIC bio, Inc. Common Stock position peaked at $1.45M in Q4 2014.
73 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2018.

Based on Regents of the University of California's 13F filing for Q2 2018, filed 13 Aug 2018.